Mechanisms of spinal cord stimulation for the treatment of pain: Still in the dark after 50 years.


Journal

European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 23 04 2018
revised: 26 09 2018
accepted: 28 10 2018
pubmed: 9 11 2018
medline: 14 6 2019
entrez: 9 11 2018
Statut: ppublish

Résumé

Despite the value of spinal cord stimulation (SCS) in treating some patients with focal neuropathic pain, technological advances in stimulator design and treatment protocols have not correlated with significant improvements in clinical outcomes. This may be because incomplete understanding of the mechanisms underlying SCS precludes improvement in clinical efficacy. In this brief review, we (a) review phenomenological effects of SCS, (b) review the literature on proposed spinal sites of action of SCS and (c) propose a novel hypothesis of mechanism of action. Dorsal columns, dorsal roots and dorsal horns have each been proposed as spinal sites of action of SCS. We suggest that evidence in favour of the dorsal columns or dorsal roots as the primary mediators of SCS is weak and propose that the dorsal horn is the crucial site of action. Furthermore, we hypothesize that, based on their location, and neurochemical and morphological properties, dorsal horn islet cells may mediate the effects of SCS. The precise spinal mechanisms of action of SCS are still unknown. Dorsal horn islet cells have properties that position them to play a key role in analgesic effects of electrical stimulation. Understanding the mechanisms responsible for positive SCS effects are needed for successful translation into clinical dividends. We review possible spinal mechanisms of action of spinal cord stimulation for neuropathic pain, proposing that direct modulation of dorsal horn neurons is crucial. We suggest that mechanistic insights are needed for translation into more favourable clinical outcomes.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Despite the value of spinal cord stimulation (SCS) in treating some patients with focal neuropathic pain, technological advances in stimulator design and treatment protocols have not correlated with significant improvements in clinical outcomes. This may be because incomplete understanding of the mechanisms underlying SCS precludes improvement in clinical efficacy. In this brief review, we (a) review phenomenological effects of SCS, (b) review the literature on proposed spinal sites of action of SCS and (c) propose a novel hypothesis of mechanism of action.
RESULTS RESULTS
Dorsal columns, dorsal roots and dorsal horns have each been proposed as spinal sites of action of SCS. We suggest that evidence in favour of the dorsal columns or dorsal roots as the primary mediators of SCS is weak and propose that the dorsal horn is the crucial site of action. Furthermore, we hypothesize that, based on their location, and neurochemical and morphological properties, dorsal horn islet cells may mediate the effects of SCS.
CONCLUSIONS CONCLUSIONS
The precise spinal mechanisms of action of SCS are still unknown. Dorsal horn islet cells have properties that position them to play a key role in analgesic effects of electrical stimulation. Understanding the mechanisms responsible for positive SCS effects are needed for successful translation into clinical dividends.
SIGNIFICANCE CONCLUSIONS
We review possible spinal mechanisms of action of spinal cord stimulation for neuropathic pain, proposing that direct modulation of dorsal horn neurons is crucial. We suggest that mechanistic insights are needed for translation into more favourable clinical outcomes.

Identifiants

pubmed: 30407696
doi: 10.1002/ejp.1336
pmc: PMC6491991
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

652-659

Subventions

Organisme : Wellcome Trust
ID : 110193/Z/15/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110193
Pays : United Kingdom

Informations de copyright

© 2018 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation ®.

Références

Neuromodulation. 2013 May-Jun;16(3):244-50; discussion 249-50
pubmed: 23009103
Pain. 2010 Nov;151(2):475-88
pubmed: 20817353
Pain. 1997 Oct;73(1):87-95
pubmed: 9414060
J Neurosci. 2005 Apr 13;25(15):3900-7
pubmed: 15829642
Neuromodulation. 1999 Jul;2(3):150-64
pubmed: 22151202
J Physiol. 2012 Aug 15;590(16):3927-51
pubmed: 22674718
Electroencephalogr Clin Neurophysiol. 1989 Jun;72(6):518-28
pubmed: 2471621
Brain Res. 1973 Mar 15;51:81-95
pubmed: 4706028
J Neurosurg. 1993 Feb;78(2):233-9
pubmed: 8421206
Pain Med. 2013 Nov;14(11):1631-49
pubmed: 23710759
Nature. 2003 Aug 21;424(6951):938-42
pubmed: 12931188
Pain. 1999 Nov;83(2):259-73
pubmed: 10534598
Acta Neurochir (Wien). 1975;31(3-4):264-5
pubmed: 1081332
J Physiol. 2007 Jun 1;581(Pt 2):603-18
pubmed: 17347278
Acta Neurochir Suppl. 1995;64:119-24
pubmed: 8748598
Exp Brain Res. 2009 Jun;196(1):139-51
pubmed: 19322562
J Physiol. 1993 Aug;468:245-59
pubmed: 8254508
J Pain Symptom Manage. 2006 Apr;31(4 Suppl):S6-12
pubmed: 16647596
Neuroimage. 2010 Feb 1;49(3):2564-9
pubmed: 19874903
Brain Res. 2014 Jun 20;1569:19-31
pubmed: 24802658
Spinal Cord. 1998 Aug;36(8):531-40
pubmed: 9713921
J Neurophysiol. 2017 Aug 1;118(2):1221-1234
pubmed: 28539396
IEEE Trans Biomed Eng. 1992 Sep;39(9):903-12
pubmed: 1335438
Anesth Analg. 1982 May;61(5):410-3
pubmed: 7199863
Eur J Pain. 2017 May;21(5):804-814
pubmed: 28107590
Annu Rev Neurosci. 2009;32:1-32
pubmed: 19400724
Spine (Phila Pa 1976). 2002 Nov 15;27(22):2574-83
pubmed: 12435996
Physiol Rev. 1984 Jan;64(1):260-324
pubmed: 6320234
Neuroscience. 2012 Jul 12;214:1-13
pubmed: 22516015
J Neurophysiol. 1993 Jun;69(6):2072-85
pubmed: 8394412
Science. 1967 Jan 6;155(3758):108-9
pubmed: 6015561
Mol Pain. 2017 Jan;13:1744806917693003
pubmed: 28326935
Pain. 1996 Aug;66(2-3):287-95
pubmed: 8880852
Neuron. 2006 Apr 6;50(1):89-100
pubmed: 16600858
Handb Clin Neurol. 2013;116:3-18
pubmed: 24112880
J Physiol. 1963 Oct;168:500-30
pubmed: 14067941
Neurosurgery. 1996 Aug;39(2):367-74; discussion 374-5
pubmed: 8832675
PLoS One. 2015 Jul 17;10(7):e0132577
pubmed: 26186201
Anesthesiology. 2010 Dec;113(6):1392-405
pubmed: 21068658
Eur J Pain. 2019 Apr;23(4):652-659
pubmed: 30407696
Eur J Neurosci. 2018 Feb;47(4):277-283
pubmed: 29356168
Neuromodulation. 2016 Feb;19(2):142-53
pubmed: 26373920
Anesth Analg. 1967 Jul-Aug;46(4):489-91
pubmed: 4952225
J Neurophysiol. 2006 Aug;96(2):579-90
pubmed: 16611846
J Neurosci. 2003 Sep 24;23(25):8752-8
pubmed: 14507975
Neurosurg Clin N Am. 1995 Jan;6(1):145-55
pubmed: 7696870
Nat Rev Neurosci. 2010 Dec;11(12):823-36
pubmed: 21068766
Neuroscience. 1997 Feb;76(3):845-58
pubmed: 9135056
Neuroscience. 2012 Jul 26;215:196-208
pubmed: 22548781
Eur J Pain. 2008 Feb;12(2):137-48
pubmed: 17977762
J Neurosurg. 1975 Mar;42(3):296-300
pubmed: 1117327
Neuromodulation. 2017 Aug;20(6):525-533
pubmed: 28568898
J Anat. 1986 Dec;149:113-9
pubmed: 2447052
IEEE Trans Biomed Eng. 1993 Jul;40(7):632-9
pubmed: 8244424
Pain. 2010 Sep;150(3):485-91
pubmed: 20591571
Pain. 1994 Oct;59(1):55-63
pubmed: 7854803
Neuroscience. 2014 Dec 26;283:95-106
pubmed: 25255936
Anesth Analg. 1967 May-Jun;46(3):299-305
pubmed: 6067264
IEEE Trans Biomed Eng. 1985 Nov;32(11):971-7
pubmed: 3877677
Pain. 1999 Feb;79(2-3):223-33
pubmed: 10068168
J R Soc Med. 2010 Nov;103(11):433-41
pubmed: 21037334
Pain Physician. 2013 Jul-Aug;16(4):405-14
pubmed: 23877457
J Neurosci. 2002 Aug 1;22(15):6724-31
pubmed: 12151551
Brain. 1984 Sep;107 ( Pt 3):671-98
pubmed: 6478175
Eur J Pain. 2016 Apr;20(4):499-511
pubmed: 26424514
Handb Exp Pharmacol. 2015;227:171-90
pubmed: 25846619
Science. 1965 Nov 19;150(3699):971-9
pubmed: 5320816
J Neurosurg. 1989 Feb;70(2):257-65
pubmed: 2913223
Neuromodulation. 2010 Jan;13(1):68-9
pubmed: 21992768
Neurosurgery. 2011 May;68(5):1452-61; discussion 1461
pubmed: 21273936
J Comp Neurol. 1980 Dec 15;194(4):781-807
pubmed: 6259218

Auteurs

Melanie P Jensen (MP)

Sobell Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Robert M Brownstone (RM)

Sobell Department of Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH